trending Market Intelligence /marketintelligence/en/news-insights/trending/fmzfwaeeryrz7u4yxqwd7q2 content esgSubNav
In This List

VTv Therapeutics secures $2.5M investment

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


VTv Therapeutics secures $2.5M investment

High Point, N.C.-based vTv Therapeutics Inc. received a $2.5 million investment from MacAndrews & Forbes Group LLC.

The drug developer exercised its right — part of a July 30 agreement — to have the investor acquire 1,879,699 of its class A common shares at $1.33 each.

VTv Therapeutics discovers, develops and sells orally administered small molecule drug candidates.